Cooper Companies Reports Mixed Q3: Sales Up, Net Income Dips

Ticker: COO · Form: 10-Q · Filed: Aug 28, 2025 · CIK: 711404

Sentiment: mixed

Topics: Medical Devices, Earnings Report, Acquisitions, Financial Performance, Healthcare Sector, 10-Q Filing, Stock Repurchase

Related Tickers: COO, JNJ, ALC

TL;DR

**COO's Q3 net income dip is a red flag despite sales growth; watch integration of new acquisitions closely.**

AI Summary

The Cooper Companies, Inc. (COO) reported mixed financial results for the three and nine months ended July 31, 2025. Net sales increased by 5.7% to $1,060.3 million for the three months and by 5.2% to $3,027.3 million for the nine months compared to the prior year periods. However, net income decreased by 6.1% to $98.3 million for the three months, down from $104.7 million, and basic earnings per share fell to $0.49 from $0.53. For the nine-month period, net income rose by 5.6% to $290.3 million from $274.8 million, with basic EPS increasing to $1.45 from $1.38. Operating income for the three months decreased to $175.7 million from $192.5 million, a 8.7% decline, primarily due to increased selling, general and administrative expenses, which rose by $40.6 million to $421.7 million. The company completed several acquisitions, including obp Surgical for $100.0 million and select Cook Medical assets for $300.0 million, expanding its CooperSurgical segment. Cash provided by operating activities significantly increased to $548.2 million for the nine months, up from $441.2 million in the prior year, while net cash used in financing activities shifted to a deficit of $261.5 million, largely due to $93.3 million in common stock repurchases.

Why It Matters

For investors, the mixed results signal a need to scrutinize the drivers behind the Q3 net income dip despite overall sales growth. The strategic acquisitions, like obp Surgical and Cook Medical assets, indicate a clear growth strategy within the CooperSurgical segment, potentially enhancing long-term market position against competitors like Johnson & Johnson or Alcon. Employees might see continued stability and growth opportunities within the expanding CooperSurgical division. Customers could benefit from an expanded product portfolio, particularly in obstetrics, doppler monitoring, and gynecology surgery. The broader market will watch how COO integrates these acquisitions and manages rising operational costs in a competitive medical device landscape.

Risk Assessment

Risk Level: medium — The company faces medium risk due to a 6.1% decrease in net income for the three months ended July 31, 2025, despite a 5.7% increase in net sales, indicating potential margin pressures. Additionally, the significant increase in selling, general and administrative expenses by $40.6 million to $421.7 million for the three-month period, and a shift to net cash used in financing activities of $261.5 million, including $93.3 million in stock repurchases, suggests a need for careful financial management.

Analyst Insight

Investors should monitor Cooper Companies' upcoming earnings calls for detailed explanations on the Q3 net income decline and the impact of recent acquisitions on future profitability. Evaluate the long-term synergy potential of the obp Surgical and Cook Medical asset acquisitions, and assess how effectively the company manages its operating expenses to restore margin growth.

Financial Highlights

debt To Equity
Not explicitly calculated, but Total Liabilities ($4,023.7M) / Stockholders' Equity (approx. $8,353M) is ~0.48
revenue
$1,060.3M
operating Margin
16.6%
total Assets
$12,376.7M
total Debt
$2,478.3M
net Income
$98.3M
eps
$0.49
gross Margin
65.3%
cash Position
$124.9M
revenue Growth
+5.7%

Revenue Breakdown

SegmentRevenueGrowth
CooperVision$1,060.3M+5.7%
CooperSurgicalNot explicitly broken out in provided textNot explicitly broken out in provided text

Key Numbers

Key Players & Entities

FAQ

What were Cooper Companies' net sales for the three months ended July 31, 2025?

Cooper Companies reported net sales of $1,060.3 million for the three months ended July 31, 2025. This represents a 5.7% increase compared to $1,002.8 million in the same period of 2024.

How did Cooper Companies' net income change in Q3 2025?

Net income for Cooper Companies decreased by 6.1% to $98.3 million for the three months ended July 31, 2025, down from $104.7 million in the prior year's comparable period.

What was the diluted earnings per share for COO for the nine months ended July 31, 2025?

For the nine months ended July 31, 2025, Cooper Companies' diluted earnings per share was $1.45. This is an increase from $1.37 reported for the nine months ended July 31, 2024.

What acquisitions did Cooper Companies complete recently?

Cooper Companies, through its CooperSurgical segment, completed the acquisition of obp Surgical for $100.0 million on August 1, 2024, and select Cook Medical assets for $300.0 million on November 1, 2023. It also acquired a fertility company for $33.5 million on June 7, 2024.

How much cash did Cooper Companies generate from operating activities?

For the nine months ended July 31, 2025, Cooper Companies generated $548.2 million in net cash from operating activities. This is a significant increase from $441.2 million in the same period of 2024.

What was the impact of stock repurchases on Cooper Companies' cash flow?

Cooper Companies repurchased $93.3 million of common stock during the nine months ended July 31, 2025. This contributed to a net cash outflow of $261.5 million from financing activities, a shift from a net inflow of $67.6 million in the prior year.

Are there any new accounting pronouncements that will affect Cooper Companies?

Yes, several. ASU 2025-05 on credit losses, ASU 2024-03 on expense disaggregation, ASU 2023-09 on income tax disclosures, and ASU 2023-07 on segment reporting are all expected to impact Cooper Companies' financial statements and disclosures in future periods, with effective dates ranging from fiscal years beginning after December 15, 2024, to December 15, 2026.

What is the total value of Cooper Companies' intangible assets?

As of July 31, 2025, Cooper Companies reported total other intangibles, net, of $1,635.9 million. This includes customer relationships, composite intangible assets, technology, trademarks, and license and distribution rights.

What is the risk associated with Cooper Companies' financial performance?

The risk level is medium. While net sales increased, the 6.1% decrease in net income for the three-month period and the rise in selling, general and administrative expenses by $40.6 million indicate potential challenges in maintaining profitability and managing operational costs effectively.

How much long-term debt does Cooper Companies have?

As of July 31, 2025, Cooper Companies had $2,431.4 million in long-term debt. This is a decrease from $2,550.4 million reported at October 31, 2024.

Risk Factors

Industry Context

Cooper Companies operates in the competitive medical device and contact lens markets. The medical device sector is characterized by innovation, regulatory hurdles, and consolidation, with companies like CooperSurgical focusing on expanding their portfolios through acquisitions. The contact lens market, served by CooperVision, is mature but sees growth driven by new product introductions and an aging global population requiring vision correction.

Regulatory Implications

As a player in the healthcare and medical device industries, Cooper Companies faces significant regulatory scrutiny from bodies like the FDA. Compliance with manufacturing standards, product safety regulations, and marketing practices is paramount. Acquisitions also bring the complexity of integrating regulatory compliance across different product lines and geographies.

What Investors Should Do

  1. Monitor SG&A expense trends
  2. Assess acquisition integration success
  3. Analyze margin performance

Key Dates

Glossary

Amortization of intangibles
The systematic allocation of the cost of an intangible asset over its useful life. This is similar to depreciation for tangible assets. (A significant non-cash expense that reduces operating income, impacting profitability. It decreased slightly to $149.4 million for the nine months.)
Goodwill
An intangible asset that arises when a company acquires another company for a price greater than the fair value of its identifiable net assets. It represents the future economic benefits arising from assets acquired in a business combination that are not individually identified and separately recognized. (A substantial asset on the balance sheet ($3,861.8M), reflecting past acquisitions and the premium paid for them.)
Other intangibles, net
Represents the net book value of identifiable intangible assets (like patents, trademarks, customer lists) acquired in business combinations, net of accumulated amortization. (A significant asset category ($1,635.9M) that has decreased from the prior year, likely due to amortization.)
Deferred tax assets
A company's right to reduce taxable income in the future or recover taxes already paid. These arise from temporary differences between accounting income and taxable income. (A large asset on the balance sheet ($2,099.2M), which has decreased from the prior year, potentially due to utilization or changes in tax rates/provisions.)
Deferred tax liabilities
A company's obligation to pay more tax in the future than is currently due, arising from temporary differences between accounting income and taxable income. (A liability on the balance sheet ($101.8M) that has increased slightly, indicating future tax obligations.)

Year-Over-Year Comparison

Compared to the prior year periods, Cooper Companies reported a 5.7% increase in net sales for the three months ($1,060.3M vs $1,002.8M) and a 5.2% increase for the nine months ($3,027.3M vs $2,877.0M). However, net income for the three-month period decreased by 6.1% ($98.3M vs $104.7M), while the nine-month net income saw a modest increase of 5.6% ($290.3M vs $274.8M). Operating income for the quarter declined 8.7% due to a significant rise in SG&A expenses. Cash flow from operations improved substantially for the nine months, but financing activities showed increased outflows due to stock repurchases. No new significant risk factors were highlighted in the provided text, but the existing risks related to acquisitions and operational costs remain pertinent.

Filing Stats: 4,724 words · 19 min read · ~16 pages · Grade level 7.4 · Accepted 2025-08-28 16:18:56

Key Financial Figures

Filing Documents

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Unaudited Financial Statements

Item 1. Unaudited Financial Statements Consolidated Condensed Statements of Income and Comprehensive Income 3 Consolidated Condensed Balance Sheets 4 Consolidated Condensed Statements of Stockholders' Equity 5 Consolidated Condensed Statements of Cash Flows 7 Notes to Consolidated Condensed Financial Statements 8

Management's Discussion and Analysis of Financial Condition and Results of Operations

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 16

Quantitative and Qualitative Disclosure About Market Risk

Item 3. Quantitative and Qualitative Disclosure About Market Risk 28

Controls and Procedures

Item 4. Controls and Procedures 28

OTHER INFORMATION

PART II. OTHER INFORMATION

Legal Proceedings

Item 1. Legal Proceedings 30

Risk Factors

Item 1A. Risk Factors 30

Unregistered Sales of Equity Securities and Use of Proceeds

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 30

Defaults Upon Senior Securities

Item 3. Defaults Upon Senior Securities 30

Mine Safety Disclosures

Item 4. Mine Safety Disclosures 30

Other Information

Item 5. Other Information 30

Exhibits

Item 6. Exhibits 31

FINANCIAL INFORMATION

PART I. FINANCIAL INFORMATION

Unaudited Financial Statements

Item 1. Unaudited Financial Statements THE COOPER COMPANIES, INC. AND SUBSIDIARIES Consolidated Condensed Statements of Income and Comprehensive Income Periods Ended July 31, (In millions, except for earnings per share) (Unaudited) Three Months Nine Months 2025 2024 2025 2024 Net sales $ 1,060.3 $ 1,002.8 $ 3,027.3 $ 2,877.0 Cost of sales 368.3 339.8 996.0 959.0 Gross profit 692.0 663.0 2,031.3 1,918.0 Selling, general and administrative expense 421.7 381.1 1,208.6 1,142.3 Research and development expense 44.6 39.0 130.8 117.4 Amortization of intangibles 50.0 50.4 149.4 151.0 Operating income 175.7 192.5 542.5 507.3 Interest expense 25.4 28.5 75.6 87.3 Other (income) expense, net ( 1.6 ) 0.3 17.2 6.3 Income before income taxes 151.9 163.7 449.7 413.7 Provision for income taxes (Note 6) 53.6 59.0 159.4 138.9 Net income $ 98.3 $ 104.7 $ 290.3 $ 274.8 Earnings per share (Note 7): Basic $ 0.49 $ 0.53 $ 1.45 $ 1.38 Diluted $ 0.49 $ 0.52 $ 1.45 $ 1.37 Number of shares used to compute earnings per share: Basic 199.3 199.1 199.6 198.8 Diluted 200.0 200.6 200.6 200.3 Other comprehensive income, net of tax: Cash flow hedges $ 3.9 $ ( 27.2 ) $ ( 17.7 ) $ ( 33.8 ) Foreign currency translation adjustment ( 3.7 ) 24.7 47.3 62.5 Comprehensive income $ 98.5 $ 102.2 $ 319.9 $ 303.5 The accompanying notes are an integral part of these Consolidated Condensed Financial Statements. 3 THE COOPER COMPANIES, INC. AND SUBSIDIARIES Consolidated Condensed Balance Sheets (In millions, unaudited) July 31, 2025 October 31, 2024 ASSETS Current assets: Cash and cash equivalents $ 124.9 $ 107.6 Trade accounts receivable, net of allowance for credit losses of $ 52.1 at July 31, 2025, and $ 43.5 at October 31, 2024 792.3 717.0 Inventories (Note 3) 881.0 802.7 Prepaid expense and other current assets 339.6 324.2 Total current assets 2,137.8 1,951.5 Property, plant and equipment, net 1,988.7 1,863.4 Goodwill 3,861.8 3,838.4 Other intangibles, ne

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing